New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy.

A new study found that users of Wegovy have nearly five times the risk of ischemic optic neuropathy (ION), compared to ...

Wegovy may raise the risk of "eye stroke" and vision loss, especially in men, compared to Ozempic due to higher doses of the ...

Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective study suggested. Over a mean ...

Arteritic anterior ischemic optic neuropathy (AAION) is a common cause of vision loss in patients with temporal arteritis. 3 Thus, temporal artery biopsy should be used to rule out temporal arteritis ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide was associated with an increased risk for nonarteritic anterior ischemic optic neuropathy — a form ...

Optic atrophy is a condition in which the optic nerve begins to deteriorate. The optic nerve is the nerve at the back of your eye that connects your eye to your brain, allowing you to see. There are a ...

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers say they have uncovered a link between semaglutide -- the active ingredient in Ozempic and Wegovy -- and the eye ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a Maryland man who developed non-arteritic anterior ischemic optic neuropathy ...

A 53-year-old man presented to the hospital after losing vision in his left eye. He explained that he had been given his second dose of Pfizer's COVID vaccine (Comirnaty) 10 days previously. He said ...